Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 August 2024. In this episode: Merck & Co. steps into CD19 bispecific space; gene therapy patients rise, but slowly; Madrigal’s Rezzdifra plans; Korean biopharma financing recovering?; and approvals to watch out for in Q3.
https://scrip.citeline.com/SC150765/Quick-Listen-Scrips-Five-MustKnow-Things
Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
view more